ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $558,103,004 | -12.5% | 20,563,854 | -0.9% | 0.02% | -11.1% |
Q2 2023 | $637,594,299 | -10.8% | 20,741,519 | +4.5% | 0.02% | -14.3% |
Q1 2023 | $715,153,783 | -6.8% | 19,848,842 | +2.2% | 0.02% | -12.5% |
Q4 2022 | $767,211,684 | +4.5% | 19,413,251 | +6.3% | 0.02% | -4.0% |
Q3 2022 | $734,092,000 | -5.1% | 18,270,089 | -0.7% | 0.02% | 0.0% |
Q2 2022 | $773,439,000 | +13.5% | 18,397,640 | +5.2% | 0.02% | +38.9% |
Q1 2022 | $681,145,000 | +2.3% | 17,483,188 | +4.6% | 0.02% | +5.9% |
Q4 2021 | $666,107,000 | +19.2% | 16,715,324 | +8.1% | 0.02% | +6.2% |
Q3 2021 | $558,754,000 | +32.5% | 15,460,845 | +50.3% | 0.02% | +33.3% |
Q2 2021 | $421,691,000 | -29.3% | 10,287,641 | -24.7% | 0.01% | -33.3% |
Q1 2021 | $596,048,000 | +31.5% | 13,664,581 | +50.9% | 0.02% | +28.6% |
Q4 2020 | $453,128,000 | +188.6% | 9,053,545 | +142.6% | 0.01% | +133.3% |
Q3 2020 | $156,989,000 | +57.7% | 3,731,632 | +82.0% | 0.01% | +50.0% |
Q2 2020 | $99,534,000 | – | 2,050,145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 3,391,754 | $134,042 | 64.43% |
Vantage Consulting Group Inc | 1,022,194 | $35,462,047 | 20.94% |
Indie Asset Partners, LLC | 462,000 | $18,258,240 | 20.01% |
Silicon Valley Community Foundation | 1,032,320 | $40,797,286 | 7.84% |
Overbrook Management Corp | 609,352 | $24,081,591 | 7.00% |
Renaissance Capital LLC | 137,462 | $5,432,498 | 4.24% |
Geo Capital Gestora de Recursos Ltd | 124,090 | $4,904 | 3.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,974,625 | $78,037,180 | 3.28% |
Lagoda Investment Management, L.P. | 119,080 | $4,706,042 | 3.18% |
VIKING GLOBAL INVESTORS LP | 10,008,511 | $395,536,355 | 1.98% |